A1 Refereed original research article in a scientific journal
A multifunctional nanocomplex for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect
Authors: Almeida PV, Shahbazi MA, Correia A, Makila E, Kemell M, Salonen J, Hirvonen J, Santos HA
Publisher: FUTURE MEDICINE LTD
Publication year: 2017
Journal: Nanomedicine
Journal name in source: NANOMEDICINE
Journal acronym: NANOMEDICINE-UK
Volume: 12
Issue: 12
First page : 1401
Last page: 1420
Number of pages: 20
ISSN: 1743-5889
eISSN: 1748-6963
DOI: https://doi.org/10.2217/nnm-2017-0034
Abstract
Aim: To evaluate the chemotherapeutic potential of a novel multifunctional nanocomposite encapsulating both porous silicon (PSi) and gold (Au) nanoparticles in a polymeric nanocomplex. Materials & methods: The nanocomposite was physicochemically characterized and evaluated in vitro for biocompatibility, cellular internalization, endosomolytic properties, cytoplasmatic drug delivery and chemotherapeutic efficacy. Results: The nanocomposites were successfully produced and exhibited adequate physicochemical properties and superior in vitro cyto- and hemocompatibilities. The encapsulation of PSi nanoparticles in the nanocomplexes significantly enhanced their cellular internalization and enabled their endosomal escape, resulting in the efficient cytoplasmic delivery of these nanosystems. Sorafenibloaded nanocomposites showed a potent in vitro antiproliferative effect on MDA-MB-231 breast cancer cells. Conclusion: The multifunctional nanocomposite herein presented exhibits great potential as a chemotherapeutic nanoplatform.
Aim: To evaluate the chemotherapeutic potential of a novel multifunctional nanocomposite encapsulating both porous silicon (PSi) and gold (Au) nanoparticles in a polymeric nanocomplex. Materials & methods: The nanocomposite was physicochemically characterized and evaluated in vitro for biocompatibility, cellular internalization, endosomolytic properties, cytoplasmatic drug delivery and chemotherapeutic efficacy. Results: The nanocomposites were successfully produced and exhibited adequate physicochemical properties and superior in vitro cyto- and hemocompatibilities. The encapsulation of PSi nanoparticles in the nanocomplexes significantly enhanced their cellular internalization and enabled their endosomal escape, resulting in the efficient cytoplasmic delivery of these nanosystems. Sorafenibloaded nanocomposites showed a potent in vitro antiproliferative effect on MDA-MB-231 breast cancer cells. Conclusion: The multifunctional nanocomposite herein presented exhibits great potential as a chemotherapeutic nanoplatform.
UTU Research Portal